Tingting Chen

756 total citations
38 papers, 523 citations indexed

About

Tingting Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tingting Chen has authored 38 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tingting Chen's work include Cancer-related molecular mechanisms research (10 papers), Cancer Genomics and Diagnostics (9 papers) and PARP inhibition in cancer therapy (4 papers). Tingting Chen is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Cancer Genomics and Diagnostics (9 papers) and PARP inhibition in cancer therapy (4 papers). Tingting Chen collaborates with scholars based in China, Macao and United States. Tingting Chen's co-authors include Tao Zhu, Wenyong Wu, Zhengsheng Wu, Gaopeng Li, Ye Yuan, Yan He, Weijie Zhang, Xiangjun Kong, Peter E. Lobie and Xiaoli Wu and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Tingting Chen

35 papers receiving 515 citations

Peers

Tingting Chen
Ruo-Pan Huang United States
Chien-Yu Chen United States
Lixia Luo United States
Wei Jiao China
Kristen N. Stevens United States
Qing Shao China
Tingting Chen
Citations per year, relative to Tingting Chen Tingting Chen (= 1×) peers Mingsong Wang

Countries citing papers authored by Tingting Chen

Since Specialization
Citations

This map shows the geographic impact of Tingting Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tingting Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tingting Chen more than expected).

Fields of papers citing papers by Tingting Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tingting Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tingting Chen. The network helps show where Tingting Chen may publish in the future.

Co-authorship network of co-authors of Tingting Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tingting Chen. A scholar is included among the top collaborators of Tingting Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tingting Chen. Tingting Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Zhang, Sibo, Tingting Chen, Wenhui Xue, et al.. (2025). Immunogenicity and cellular response of a herpes zoster virus gEgI fusion protein adjuvanted with CpG-emulsion in mice. Journal of Nanobiotechnology. 23(1). 395–395. 1 indexed citations
4.
Li, Ying, Tingting Chen, Weichen Qi, et al.. (2025). A visual monitoring DNA‐free multi‐gene editing system excised via LoxP::FRT/FLP in poplar. Plant Biotechnology Journal. 23(9). 4017–4029. 1 indexed citations
6.
Chen, Tingting, et al.. (2024). Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia. Frontiers in Immunology. 15. 1451486–1451486. 2 indexed citations
7.
Chen, Tingting, Yuquan Wang, Yan Wang, et al.. (2023). Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages. Computational and Structural Biotechnology Journal. 21. 5751–5764. 8 indexed citations
8.
Xu, Yuyan, Jian‐Peng Cai, Lei Cai, et al.. (2023). Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection. Frontiers in Oncology. 13. 1119744–1119744. 13 indexed citations
9.
Jiang, Li, Tan Wu, Kai Song, et al.. (2022). Integrative network analysis reveals subtype-specific long non-coding RNA regulatory mechanisms in head and neck squamous cell carcinoma. Computational and Structural Biotechnology Journal. 21. 535–549. 6 indexed citations
10.
Chen, Bo, Pengfei Li, Mingyue Liu, et al.. (2022). A genetic map of the chromatin regulators to drug response in cancer cells. Journal of Translational Medicine. 20(1). 438–438. 4 indexed citations
11.
Chen, Tingting, Jiayi Wang, Bo Chen, et al.. (2022). Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade. British Journal of Cancer. 127(5). 916–926. 7 indexed citations
12.
Zou, Min, Yawei Li, Zhangxiang Zhao, et al.. (2022). Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma. Molecular Oncology. 16(16). 3034–3051. 17 indexed citations
13.
Chen, Tingting, Yingying Guo, Jiayi Wang, et al.. (2021). LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation. Cell Death and Disease. 12(6). 600–600. 14 indexed citations
14.
Zhao, Zhangxiang, Yingying Guo, Yaoyao Liu, et al.. (2021). Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer. Oncogene. 40(27). 4604–4614. 24 indexed citations
15.
Dong, Qi, Mingyue Liu, Bo Chen, et al.. (2021). Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome. Computational and Structural Biotechnology Journal. 19. 4435–4446. 4 indexed citations
16.
Chen, Tingting, et al.. (2021). Detection of a novel antigen for Crohn’s disease. Scandinavian Journal of Gastroenterology. 56(12). 1427–1433. 2 indexed citations
17.
Han, Yue, Chengyu Wang, Qi Dong, et al.. (2019). Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells. Molecular Therapy — Nucleic Acids. 17. 688–700. 14 indexed citations
18.
Du, Jingjing, Pengzhou Hang, Yang Pan, et al.. (2019). Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway. Toxicology and Applied Pharmacology. 369. 73–81. 63 indexed citations
19.
Zou, Shasha, Zheng Li, Yanan Wang, et al.. (2014). Association Study Between Polymorphisms of PRMT6, PEX10, SOX5, and Nonobstructive Azoospermia in the Han Chinese Population1. Biology of Reproduction. 90(5). 96–96. 17 indexed citations
20.
Kong, Xiangjun, Gaopeng Li, Ye Yuan, et al.. (2012). MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression. PLoS ONE. 7(8). e41523–e41523. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026